RNXT
Price:
$1.02
Market Cap:
$24.47M
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.[Read more]
Industry
Biotechnology
IPO Date
2021-08-26
Stock Exchange
NASDAQ
Ticker
RNXT
According to RenovoRx, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.70. This represents a change of -42.75% compared to the average of -2.97 of the last 4 quarters.
The mean historical PE Ratio of RenovoRx, Inc. over the last ten years is -8.31. The current -1.70 PE Ratio has changed 1.94% with respect to the historical average. Over the past ten years (40 quarters), RNXT's PE Ratio was at its highest in in the June 2022 quarter at -1.74. The PE Ratio was at its lowest in in the June 2020 quarter at -19.69.
Average
-8.31
Median
-6.09
Minimum
-16.65
Maximum
-2.18
Discovering the peaks and valleys of RenovoRx, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 5.79%
Maximum Annual PE Ratio = -2.18
Minimum Annual Increase = -64.27%
Minimum Annual PE Ratio = -16.65
Year | PE Ratio | Change |
---|---|---|
2023 | -2.30 | 5.79% |
2022 | -2.18 | -64.27% |
2021 | -6.09 | -57.51% |
2020 | -14.34 | -13.89% |
The current PE Ratio of RenovoRx, Inc. (RNXT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.52
5-year avg
-8.31
10-year avg
-8.31
RenovoRx, Inc.’s PE Ratio is greater than Axcella Health Inc. (-10.73), less than Adial Pharmaceuticals, Inc. (-0.34), less than Better Therapeutics, Inc. (-0.00), less than Pasithea Therapeutics Corp. (-0.27), greater than ZIVO Bioscience, Inc. (-2.46), less than Quoin Pharmaceuticals, Ltd. (-0.47), greater than ARCA biopharma, Inc. (-58.03), greater than Nutriband Inc. (-6.76), less than Longeveron Inc. (-0.66), less than Virax Biolabs Group Limited (-1.34), greater than Anebulo Pharmaceuticals, Inc. (-4.99), less than SAB Biotherapeutics, Inc. (-0.65), less than Monopar Therapeutics Inc. (-1.18), less than Eledon Pharmaceuticals, Inc. (-1.43), less than Tempest Therapeutics, Inc. (-0.88), less than Ikena Oncology, Inc. (-1.22), less than Catalyst Biosciences, Inc. (-0.44),
Company | PE Ratio | Market cap |
---|---|---|
-10.73 | $0 | |
-0.34 | $6.40M | |
-0.00 | $5.45K | |
-0.27 | $4.37M | |
-2.46 | $37.03M | |
-0.47 | $3.06M | |
-58.03 | $34.82M | |
-6.76 | $49.16M | |
-0.66 | $28.29M | |
-1.34 | $15.24M | |
-4.99 | $46.68M | |
-0.65 | $26.21M | |
-1.18 | $8.41M | |
-1.43 | $100.73M | |
-0.88 | $31.26M | |
-1.22 | $81.56M | |
-0.44 | $19.42M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RenovoRx, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like RenovoRx, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is RenovoRx, Inc.'s PE Ratio?
How is the PE Ratio calculated for RenovoRx, Inc. (RNXT)?
What is the highest PE Ratio for RenovoRx, Inc. (RNXT)?
What is the 3-year average PE Ratio for RenovoRx, Inc. (RNXT)?
What is the 5-year average PE Ratio for RenovoRx, Inc. (RNXT)?
How does the current PE Ratio for RenovoRx, Inc. (RNXT) compare to its historical average?